D.E. Shaw & Co’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.4M | Sell |
|
|||||
|
2025
Q1 | $39M | Sell |
|
|||||
|
2024
Q4 | $59.5M | Sell |
|
|||||
|
2024
Q3 | $53.9M | Buy |
|
|||||
|
2024
Q2 | $47.7M | Buy |
|
|||||
|
2024
Q1 | $48.9M | Sell |
|
|||||
|
2023
Q4 | $118M | Sell |
|
|||||
|
2023
Q3 | $99.8M | Sell |
|
|||||
|
2023
Q2 | $126M | Buy |
|
|||||
|
2023
Q1 | $92.2M | Buy |
|
|||||
|
2022
Q4 | $67.2M | Sell |
|
|||||
|
2022
Q3 | $77.1M | Buy |
|
|||||
|
2022
Q2 | $66M | Buy |
|
|||||
|
2022
Q1 | $110M | Buy |
|
|||||
|
2021
Q4 | $106M | Sell |
|
|||||
|
2021
Q3 | $92.5M | Buy |
|
|||||
|
2021
Q2 | $116M | Buy |
|
|||||
|
2021
Q1 | $60.8M | Buy |
|
|||||
|
2020
Q4 | $120M | Sell |
|
|||||
|
2020
Q3 | $93.4M | Buy |
|
|||||
|
2020
Q2 | $104M | Buy |
|
|||||
|
2020
Q1 | $54.5M | Sell |
|
|||||
|
2019
Q4 | $58.9M | Sell |
|
|||||
|
2019
Q3 | $81.8M | Buy |
|
|||||
|
2019
Q2 | $50.8M | Buy |
|
|||||
|
2019
Q1 | $38.7M | Buy |
|
|||||
|
2018
Q4 | $2.42M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $859K | Buy |
|
|||||
|
2018
Q1 | – | Hold |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $694K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $219K | Sell |
|
|||||
|
2016
Q4 | $1.48M | Sell |
|
|||||
|
2016
Q3 | $3.37M | Buy |
|
|||||
|
2016
Q2 | $254K | Sell |
|
|||||
|
2016
Q1 | $799K | Sell |
|
|||||
|
2015
Q4 | $2.31M | Buy |
|
|||||
|
2015
Q3 | $1.55M | Buy |
|
|||||
|
2015
Q2 | $1.9M | Buy |
|
|||||
|
2015
Q1 | $960K | Sell |
|
|||||
|
2014
Q4 | $5.53M | Buy |
|
|||||
|
2014
Q3 | $3.36M | Buy |
|
|||||
|
2014
Q2 | $2.87M | Buy |
|
|||||
|
2014
Q1 | $1.53M | Sell |
|
|||||
|
2013
Q4 | $1.77M | Buy |
|
|||||
|
2013
Q3 | $1.09M | Sell |
|
|||||
|
2013
Q2 | $1.77M | Buy |
|